Company
Pneuma Respiratory
Next-generation aerosol technologies enabling precise, efficient delivery across small molecules, biologics, and emerging modalities.
Also known as Pneuma Respiratory, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Boone, NC, United States
Claim, correct or request removal
Record updated 19 October 2026
About
Pneuma’s platform is a pulmonary delivery system built on advanced aerosol generation physics. It enables low-shear delivery of fragile biologics and high-efficiency deposition of small-molecule therapies through precise, breath-actuated aerosol control.
Funding snapshot
- Total raised
- $34.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $3.6M2026-06-18
Funding rounds
- Round, 2026
- $3.6M2026-06-18, SEC form D sold
- Round, 2025
- $3.3M2025-02-10, SEC form D sold, 14 investors
- Round, 2024
- $3M2024-12-31, SEC form D sold, 26 investors
- Round, 2023
- $7.3M2023-06-20, SEC form D sold, 68 investors
- Round, 2020
- $430K2020-08-21, SEC form D sold, 18 investors
- Round, 2020
- $438K2020-06-18, SEC form D sold, 4 investors
- Round, 2019
- $6.9M2019-07-15, SEC form D sold, 36 investors
- Round, 2019
- $5M2019-02-25, SEC form D sold, 34 investors
- Round, 2018
- $8.1M2018-03-13, SEC form D sold, 52 investors
Products
- Hardware
- Therapeutic Aerosol Platform for Pulmonary Drug Delivery
Loading relationship preview